Exam Questions Flashcards
(202 cards)
AA2Outline the key product design variations for critical illness benefits that you are likely to find in the market. [3]
PRODUCTS_CI; ASSA NOV 2022; Q5
- Accelerator, rider or stand-alone benefit✓✓
- May be a traditional non-profit product✓, indexed premiums or benefit✓ or UL product✓
- Tiered benefits✓✓ – variations in whether benefits are tiered or not✓, the number of tiers✓ and the differentials in sum assured in the tiers✓.
- Whether multiple reinstatements are permitted or not ✓✓
- Variations in the number and types of diseases covered ✓✓
- Cover terminating at different ages ✓✓
- Variations in definitions of diagnoses ✓✓
- Variations in deferred period ✓✓
- Speciality benefits✓ – women only✓, children’s benefit add-on✓, TPD✓/terminal benefit✓
ST1 April 2021 Q1(i) [11]
ST1 Sep 2022 Q4 (iii) & (iv) [12]
A student in the analytics team at a large health insurer is carrying out an analysis of experience on the previous year’s hospital claims using a generalised linear model (GLM). The student has developed two potential models. The two models are identical except for the second model having both income band and geographic location as additional factors.
(i) List two properties of the exponential family of distributions which make them particularly useful when using a GLM. [1]
(ii) Explain which two tests can be used to analyse the significance of the additional factors in the second model. [2]
(iii) List two other checks that should be carried out before including additional factors into a model. [1]
[4 marks]
F102 Nov 2015, Q2 [4]
ii.
o The distribution is completely specified in terms of its mean and variance.
[1/2]
o The variance of Yi (the response variable) is a function of its mean.
[1/2]
ii.
The two models are nested models.[1/2]
o Where the scale parameter is known[1/4], the χ2 test for the change in scaled deviance can be used.
[1/2]
o Where the scale parameter is unknown[1/4], the F statistic can be used as the ratio of the change in the deviance and the scale parameter estimate is distributed with an F-distribution.
[1/2]
iii.
o Consistency of the factor over time.
[1/2]
o Consistency of the factor with other factors.
[1/2]
You are an actuary working for a health insurer developing a new health insurance product that specifically focuses on primary healthcare.
iii.Explain the various benefit design structures that could be used to clearly define the benefit entitlement in this new primary healthcare insurance product. [3]
Products; ASSA JUNE 2023; Q5(iii)
Frequency design
This design limits the number of visits a policyholder can make to a primary healthcare provider✓✓, such as a GP or nurse practitioner✓, during a certain period, such as a year.✓
Depending on the budgetary constraints of the target market✓, the product can offer unlimited frequency of benefits✓, e.g. unlimited GP visits✓.
Monetary amount design
This design sets a limit on the total amount that the insurer will pay for primary healthcare services✓✓, such as GP visits or diagnostic tests✓, during a certain period✓.
Unit design
The design of the benefit needs to specify the unit of the benefit entitlement, which is typically “per life” or “per family”✓✓.
The design of the benefit also needs to be specific to the time period✓ of the benefit entitlement, which is typically “per annum”✓, but can also be “per lifetime”✓.
For example, 4 GP consultations per family per annum✓.
Co-payments/cost sharing
This design requires the policyholder to pay a certain percentage of the cost of a primary healthcare service✓✓, such as a GP visit or medication✓.
The co-payment can be expressed as a monetary amount✓, or it can be a percentage of the cost✓.
Scope of cover✓
Do the benefits include consultations✓…
…and/or medication✓…
…and/or minor in-room procedures✓…
…and/or basic pathology✓ and radiology✓.
The richness of the benefits can further be determined by the provider network ✓– the wider the network, the more accessible healthcare becomes✓.
Medical savings account
Some benefits may not be funded from risk element of the premiums, but rather by MSA✓✓.
Q&A 3.1 [4]
X3.1 (ii) [3]
The company will not have the same experience as the industry average, due to differences in such things as: ●
● ● ● ● ● ●
sales method and distribution channel target market
products or product features
level of any surrender values paid quality of after-sales service relative competitiveness company reputation.
[1⁄2] [Maximum 4] [1⁄2] [1⁄4 each, ,maximum 11⁄2]
Industry data will be a heterogeneous mix of the above factors, and the great variation in withdrawal experience between the different companies will make the industry average a very poor indicator of the level of withdrawals for any individual company.
[1⁄2]
Also, industry statistics may be wrong, unavailable, out of date or not presented in sufficient detail.
[1⁄2]
The effect of heterogeneity in the industry data can also give rise to spurious trends in experience observed over time, through changes in the mix of companies that comprise the industry statistics.
[1⁄2]
[Total 3]
ST1 S2010 Q2 [6]
ST1 April 2021 Q6 (ii) [7]
June 2022 Q7 (i)-(iii) [7]
A health insurer selling PMI policies has historically sold only individual policies through the use of independent intermediaries only.
As a second recommendation from the head of marketing, he suggests the company looks into expanding its policy base by selling to employer groups.
The insurance company currently has stringent and well-established managed care interventions in place, across its various benefit categories.
vii. Explain how the insurance company would have to tailor its managed health care interventions for group PMI business. [3]
MANAGED CARE_F101 NOV 2022; Q3 (vii)
- Hospital networks should be to evaluated in the areas in which large employers are based✓✓, ie need to have hospitals within a reasonable radius from the majority of employee base as part of the network✓.
- Specialist networks should be established/re-evaluated in the medical areas that the employees are most at risk of needing treatment from.✓✓
- o (This would also apply to Family Practioners (“GPs”) as well as pharmacy networks.✓✓
- Wellness days✓ (eg for preventative health screenings)✓ should rather take place at the workplace (employer)✓ than at the wellness day events target for individual policyholders✓.
- The wellness communications should be tailored to the specific characteristics of the employer✓, eg mining workers and call centre agents would have different health challenges✓.
- Could recruit a doctor/nurse to be based at the employers’ location to deal with employees’ medical problems as soon as they arise✓✓, or a tele-health solution✓ (eg virtual 24/7 nursing service)✓.
- Should try and extend managed care interventions to be put into practice for the employers themselves✓, eg minimum standards of health and safely within the workplace✓.
Company B is a health and care insurance company specialising in long-term CI insurance business.
Company B currently reinsures a significant proportion of its critical illness business to external reinsurers. For a number of years the total premiums paid to the reinsurers by Company B has been higher than the corresponding reinsurance recoveries.
The Finance Director of Company B has expressed concerns that reinsurance does not represent good value for money for Company B.
The Finance Director has asked an actuary to carry out an investigation into how
reinsurance impacts the profitability of Company B’s critical illness business.
Having reviewed the actuary’s investigation, the Finance Director has agreed that it is
appropriate to continue reinsuring a significant proportion of Company B’s critical
illness business to external reinsurers. The Finance Director has asked if there are any
actions which could be taken to improve the cost effectiveness of Company B’s reinsurance arrangements.
(iii) Suggest possible actions Company B could take to make its existing reinsurance arrangements more cost effective. [6]
Reinsurance; UK SEP 2020; Q5 (iii)
UK SEP 2020; Q5 (iii)
iii. Outline the advantages of the Tweedie distribution for modelling PMI claims data. (2)
GLM; ASSA NOV 2014; Q5 (iii)
Direct modelling of risk premium or incurred loss data✓ for PMI business is problematic since a typical pure premium distribution will consist of a large spike (ie a point mass) at zero✓✓ (where policies have not had claims)✓ and then a wide range of amounts (where policies have had claims)✓.
The Tweedie distribution is a special member of the exponential family✓ that has a point mass at zero✓ and corresponds to the compound distribution of a Poisson claim number✓ process and a gamma claim size distribution✓.
You work for an established Managed Care Organisation (MCO) and will be tendering to a large health insurer for a contract to provide their Managed Care interventions.
Identify four managed care interventions you can offer the insurer and explain how these will assist the insurer in managing its risk. [6]
MANAGED CARE; ASSA JUNE 2023; Q7 (ii)
Pre-authorisation of hospital admissions✓✓
o Providing a service that authorises (or not) all planned hospital admissions ✓✓
o Ensure that admission is covered within stated policy benefits ✓
o Ensure that applicable co-payments are levied; or if limits reached, that claims are not authorised ✓✓
o Communicate to both policyholder/insurer outcome of pre-auth ✓
o Ensure network hospitals used ✓
High-cost case management ✓✓
o Monitor and intervene in care of high-cost cases ✓
o Reduce wastage/unnecessary services/ensuring protocols followed ✓✓
o Assist with discharge planning ✓
o Communication of alternatives with family members ✓
o Setting of care management ✓
Preferred provider networks ✓✓
o Decide which hospitals, doctors, specialists, pharmacies to include in networks ✓✓
o Ensure policyholders aware, and only use DSP’s ✓✓– levy co-payments elsewise ✓
o Can secure volume discounts ✓
Treatment protocols ✓✓
o Set treatment standards for in- and out-of-hospital treatments ✓
▪ To ensure quality of care and reduce unnecessary care ✓✓
o Monitor adherence to protocols; intervene if not followed ✓✓
o Assists in managing costs ✓
Medicine formularies ✓✓
o For various classes of drugs; or diagnoses, specify specific drugs covered ✓✓
o E.g. generics where exists; ✓ alternatively members pay difference ✓
o Ensures appropriate medication at best price.✓
Alternative reimbursement arrangements✓✓
o Can contract with providers – negotiate tariffs/volume discounts, etc. ✓✓
o Risk sharing arrangements✓, e.g. capitation, fixed fees, per diem rates ✓✓
o Reduces incentives created by FFS/manages costs ✓
o Can incentivise quality – sharing in upside benefit (on risk-adjusted basis) ✓
Quality measurement and reporting ✓✓
o Across all Managed care interventions; monitor impact and report on key quality metrics ✓
o Analyse utilisation and performance by providers – across networks✓ – on risk-adjusted basis ✓
o Use results to intervene or amend contracting ✓✓
o Or update protocols, formularies, etc. to improve future experience ✓✓
= 4 X 1.5 marks
X2.3
A country has a well-established private health insurance industry that services approximately 20% of the population, while the balance relies on State facilities (which they can access for free). The Government is considering establishing Social Health Insurance (SHI) for employed people earning above a defined income threshold. It would be compulsory for individuals earning above the income threshold to contribute a defined percentage of their income to SHI. Individuals may elect to buy additional private health insurance cover for benefits in excess of those covered by SHI.
(i) Discuss whether the Government should provide the SHI benefits through its own health facilities or contract with private healthcare facilities, which offer a higher quality service. [4]
(ii) Discuss whether the SHI premium should be set as a fixed percentage of salary. [3]
[Total 7]
(i)
Own healthcare facilities
The feasibility of using State facilities to provide the SHI benefits will depend on capacity of State facilities …[1⁄2]
… and level of quality of care. [1⁄2]
Using State facilities means more control over costs and claims. [1⁄2]
In addition, it would avoid paying high prices (that lead to private industry profits). [1⁄2]
Lives that were previously not covered privately may perceive that they are paying for something they were getting for free in the past. [1⁄2]
Lives that previously had private health insurance are unlikely to want to use State facilities. [1⁄2]
However, SHI funds can be used to improve facilities. [1⁄2]
Private healthcare facilities
On the other hand, by contracting with private healthcare facilities, the SHI fund can benefit from:
- expertise and economies of scale in the private sector [1⁄2]
- competition between providers, and hence lower prices. [1⁄2]
Checks and controls would be needed to prevent abuse (eg overcharging for medical treatment). [1⁄2]
The capacity of the private sector capacity needs to be assessed in order to determine whether additional lives can be accommodated. [1⁄2]
A phasing approach can be used in which SHI benefits are extended to lower income groups by lowering the salary threshold over time. [1⁄2]
State facilities will need to continue to service the population that is not covered by SHI, or do not want to make use of private healthcare facilities. [1⁄2]
(co-existence)
(ii)
Setting the SHI premium as a fixed percentage for all income levels means that higher income earners pay more (in monetary terms) than lower income earners for same cover. [1⁄2]
This approach therefore creates large income cross-subsidies, … … but this may be socially desirable. [1⁄2]
The extent of these cross-subsidies will depend on income distribution of the country concerned. [1⁄2]
This approach could be modified by basing the premiums on a reducing percentage of salary, …[1⁄2]
… with a maximum absolute amount for the highest income earners (to make it more palatable for high income earners!) but still have some degree of cross-subsidy. [1⁄2]
It will also need to be considered whether the % is of total salary or salary above the threshold. [1⁄2]
The latter is “more fair” to avoid discontinuity for those moving from just below the threshold to just above it. [1⁄2]
Q&A 3.16 [5]
Target Health is a large and well-established health insurer. Target Health is considering the
acquisition of StarMed, a small health insurer. Both insurers offer PMI in various product options covering both in- and out-of-hospital.
iii. Explain how you would use a Generalised Linear Model to estimate the claims experience of Target Health after the acquisition.
[5]
GLM; ASSA NOV 2020; Q4 (iii)
- If there is an existing GLM built off of Target Health claims data, then this model can be used✓✓ alternatively a GLM model for Target Health claims data will need to
be built✓. - To do this:
- Collect claims data for Target Health policies✓ based on historical claims costs per benefit type✓ and per benefit option✓.
- Need to ensure the credibility of data per cell.✓✓
- Claims will need to be determined on a per life per month (PLPM) basis per benefit option.✓✓
- This is done by taken the total claims per cell and dividing by the exposure in that cell.✓✓
- If using historical claims data, may need to adjust claims costs✓ for inflation✓, runoff✓
and any benefit changes✓. - Identify the risk factors that need to be accounted for✓ (usually the ones to influence claims behaviour) such as age, gender and chronic status✓✓.
- The choice of GLM and link function needs to be reasonable and appropriate.✓✓
- A gamma model may be a good option for claim amounts.✓✓
- Running the GLM will give a set of factors per risk factor (age, gender, chronic status), benefit amount type and benefit option type.✓✓
- These factors can then be used to score StarMed members based on their risk factors and the option they have been mapped to.✓✓
- This will yield claims estimates for the StarMed members if they were on Target Health’s benefit options.✓✓
- These costs can be compared to the existing Target Health polices on that benefit option as well as compared to the expected premium income to determine the extent of a surplus/deficit.✓✓
- For accuracy sensitivity testing should be done, as well as a variety of scenarios determined.✓✓
ST1 S2010 Q3 [15]
An insurance company is considering entry to the group risks market for a wide range
of health and care contracts.
(ii) Describe the sources of medical information typically used in underwriting such a private medical insurance policy. [3]
(iii) Describe how a moratorium clause may be used to manage risk as an alternative to medical underwriting. [4]
(iv) Describe how the application of medical underwriting for health insurances differs for group policies as opposed to individual policies. [12]
Risks_UK ST1 2005 APR Q8 (ii)
- Questions answered on the proposal form completed by the applicant.✓✓
- Reports from medical doctors that the applicant has consulted✓✓, eg a PMAR✓.
- Medical examination carried out on the applicant at the request of the insurer✓✓. eg an exam carried out by a doctor or nurse appointed by the insurer✓.
- Specialist medical test on the applicant✓✓, eg an HIV test.✓
The last three sources will involve an additional expense for the insurer.✓✓ Hence the extent that they are used in a particular case depends on the extent of the loss that the insurer will make if it mis-estimates the state of health of the applicant.✓✓
i. List the disadvantages of the formula approach to pricing healthcare policies. [4]
ii. Discuss the appropriateness of using a formula approach for pricing the following policies:
a. An annually reviewable group PMI policy. [3]
- It does not allow for the proper timing of events.✓✓
- It does not allow for the accumulation of reserves.✓✓ In fact, reserves are ignored completely when using this approach.✓
- It does not properly allow for capital needs.✓✓ It is not possible to allow for the desired rate of return required by shareholders on their capital.✓ In effect we assume that any capital needed can be borrowed at the discount rate used.✓ This is important for capital implications.✓
- It does not allow for the impact of net negative cashflows in any period.✓✓
- It does not allow for separate inspection of premium-related cashflows or claim-related cashflows.✓✓ We cannot track expenses, claims, premiums etc separately each year.✓
- It does not allow easily for variation of assumptions over time.✓✓ The approach uses one fixed discount rate, whereas investment returns might vary over time.✓
- It does not allow for changes in the assumed future experience✓✓ and cannot be used to measure the sensitivity of profit to such variations.✓
- It cannot easily allow for more complicated product structures✓✓, eg UL✓.
ii.
The product is short term✓ in nature and annually reviewable✓. This means that a long-term projection of capital and solvency requirements is not necessary.✓✓
- Similarly, there shouldn’t be a need to vary assumptions✓✓ over the term of the policy given that it is a short-term product.
- While a lot of thought will go into calculating the expected level of claims, it is unlikely that the insurer will need to separately inspect the claims related cashflows.✓✓ Similarly, premiums will not vary over the course of the month given that it is a group product.✓✓
- Therefore, a formula approach could be utilized for pricing this type of product.✓✓
X2.4
Question X2.4
The health and care insurance industry in a small country has grown rapidly over the last ten years. The government, through its regulator, has decided to review the regulations that are in place to restrict the ways that health and care insurance companies operate. The main aim of the restrictions is to provide protection for the policyholders.
Describe the regulatory restrictions that could be imposed on health and care insurers, and discuss how they help to achieve the stated aim of consumer protection.
[9]
Solution X2.4 ●
A restriction on the types of contract, … [1⁄2]
… and/or the features, options and guarantees that a health and care insurance company can offer.
[1⁄2]
This may prevent companies from offering contracts that are not suitable for policyholders, or for which the company is not able to support.
[1⁄2] ●
Restrictions on the premium rates, or charges, that may be used for some types of contract.
[1⁄2]
A maximum rate of premium will help to ensure that products do not give poor value for money.
[1⁄2] ●
Some or all of the pricing assumptions might be specified, again to ensure value for money.
[1⁄2]
A minimum premium will help protect the financial security of the company and hence the security of its policyholders.
[1⁄2] ● Requirements relating to the terms and conditions of the contracts, … … for example the claim definitions to be used. ● Restrictions on sales channels that can be used, … [1⁄2] [1⁄2] [1⁄2]
… or requirements on the procedures that should be followed or information that must be given when a sale is made.
[1⁄2] [1⁄2]
This will help policyholders understand the product that they are buying and ensure that the most appropriate type of product is sold to the customer.
It may also expose costs or charges that the policyholder will have to pay and so enable the policyholder to choose the product that gives the best
Restrictions on the ability to underwrite, … [1⁄2] … for example a prohibition on the use of the results of genetic testing. This will help prevent policyholder discrimination. ● A constraint on the amount of business that may be written, … [1⁄2] [1⁄2] [1⁄2]
… possibly by using a minimum solvency margin that depends on the level of business, …
[1⁄2]
… which itself may be a function of specified reserving methods and/or assumptions. [1⁄2]
This will help protect the financial security of the company and hence the security of its policyholders.
[1⁄2] ●
Restrictions on the types of asset that may be used to demonstrate solvency, … [1⁄2]
… or the amount of any particular asset that may be used for this purpose. [1⁄2]
This restriction could prevent or limit investment in very high-risk assets and so reduce the risk of insolvency.
[1⁄2]
It could also prevent over-concentration in a particular class or sector and this will also reduce the risk to the policyholder.
●
Conditions might be imposed on the persons who are allowed to become directors of health and care insurance companies.
[1⁄2] [1⁄2]
This would help to protect policyholders from the effects of unsound management. [1⁄2]
●
Companies could be required to contribute to a security fund from which policyholders could be compensated for malpractice.
[1⁄2] [Maximum 9] ©
ST1 2019 Q6 [11]
You are an actuary working for an insurer selling long-term care insurance (LTCI) policies.
i.Describe various benefit design features of LTCI products that can assist the insurer with managing the claims risk associated with these products and
how they may impact marketability. [5]
PRODUCT DESIGN; ASSA JUNE 2023; Q3
For indemnity products✓, have agreements in place with providers of care✓.
May limit choice for policyholders for carers and settings of care✓, reducing marketability✓
- Offering cash not indemnity benefits✓✓
Indemnity is likely to be very expensive✓ given the uncertain increases in cost of care✓ – especially if specialised/nursing care✓ is covered.
Policyholders will prefer indemnity, however, this would make the products prohibitively expensive, so cash benefit products may still be marketable.✓✓
- Having a deferred period✓ – the longer the deferred period, the less the risk✓, however, may leave policyholders vulnerable during the deferred period✓
- Limited payment term after inception✓ – may be very unpopular✓ – vulnerable policyholders after term elapsed✓
- Definitions of incapacity✓ – the more stringent, the less the risk✓,
o However, significant negative impact on marketability if too stringent✓. - Unit-linked designs✓✓
o Transfers some/all investment risk to policyholder✓
Depending on fund protection and or guarantees✓✓
o Policyholders may find unit-linked options attractive as it acts like a savings policy in case they don’t claim✓✓
o However, these will be very complex✓ – charges, investment funds, returns✓✓, etc. – which may impact marketability✓
o Also, risk of policyholder not understanding their risks✓, i.e. the impact of risk charges reducing unit fund value✓; and negative press✓ may affect future marketability✓
o Level of unit fund protection✓ – lower (or no) fund protection significantly reduces the risk to insurer✓, and marketability reduced✓
Policyholders value the security of knowing some of their investment is protected✓✓
o Knowing fund value may be depleted if risk charges exceed investment returns✓✓, and that there is even a risk of cover lapsing in the absence of guarantees if fund value becomes exhausted✓ – will impact marketability✓
However, insurer may offer a guarantee that cover will not lapse if fund becomes depleted✓ – added risk✓, but added marketability✓ and better match to policyholders’ needs✓.
Company B is a health and care insurance company specialising in long-term critical
illness insurance business.
Company B currently reinsures a significant proportion of its critical illness business
to external reinsurers. For a number of years the total premiums paid to the reinsurers
by Company B has been higher than the corresponding reinsurance recoveries. The
Finance Director of Company B has expressed concerns that reinsurance does not
represent good value for money for Company B.
The Finance Director has asked an actuary to carry out an investigation into how
reinsurance impacts the profitability of Company B’s critical illness business.
(i) Discuss how the actuary could carry out this investigation.
[7]
Reinsurance; UK SEP 2020; Q5 (i)
Reinsurance; UK SEP 2020; Q5 (i)